Cancer
CD22 antigen (HLA-A*02:01) PLSEGPHSL
€105.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
3 weeks
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Product number: EP07885_1
Description
Antigen Peptide CD antigen HLA- A*0201 (PLSEGPHSL) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays
TechData
| Sequence: | PLSEGPHSL |
| Gene: | MS4A1 |
| Delivery: | 3 weeks |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | B-lymphocyte antigen CD20 |
| Species: | Human |
| Allele: | HLA-A*02:01 |
| Application: | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
| Indication: | Cancer, Neuroscience, Autoimmune disease |
| Purity: | 95% HPLC-MS |